|
Go To
Fortune
500 Job Source
Illinois
Job Source
Add
Your Resume
|
Abbott
Laboratories
Develops pharmaceutical and medical products.
Headquarters:
100 Abbott Park Rd.
Abbott Park, IL 60064
Employees: 72,000
CEO: Miles White
Stock Symbol: ABT
Website:
http://www.abbott.com
Company News
Career
Site
Founded in 1900 by Dr. Wallace Calvin Abbott,
a Chicago physician, Abbott Laboratories has emerged as one of
the world's top health care companies. Today, Abbott discovers,
develops, manufactures, and markets products and services that
span the continuum of care from prevention and diagnosis,
to treatment and cure.
More than 5,000 Abbott scientists around the world are committed to developing new, innovative health care technologies in the key therapeutic areas of: diabetes, pain management, respiratory infections, HIV/AIDS, men's and women's health, pediatrics and animal health. In 2009, Abbott devoted $2.74 billion on research and development.
HUMIRA is the company's top-selling drug
and is used to treat rheumatoid arthritis, psoriatic arthritis,
ankylosing spondylitis and Crohn's disease.
Niaspan is a top drug in the U.S. for Abbott which is used to treat high cholesterol.
Abbott serves customers in over 130 countries.
It has more than 100 manufacturing, distribution, research and
development, and other locations around the world.
Some of the producs Abbott is working on include:
* Oncology
o Abbott's oncology pipeline includes targeted therapies that represent promising, unique scientific approaches to treating cancer. Our collaboration with Genentech to develop two Abbott-discovered compounds continues to progress. These compounds include ABT-869, a multi-targeted kinase inhibitor and ABT-263, a Bcl-2 family protein antagonist.
o Abbott's oncology research also includes a PARP-inhibitor, which prevents DNA repair in cancer cells, enhancing the effectiveness of current cancer therapies.
* Neuroscience
o Abbott is conducting innovative research in neuroscience, where we've developed compounds that target receptors in the brain that help regulate mood, memory and other neurological functions to address conditions such as attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia. Abbott is also working to advance compounds that have the potential to meet the market need for a non-opioid pain therapy. Our work in neuroscience is focused on several promising investigational platforms including NNRs, H3, Calpain and TRPV1, among others.
* Immunology
o Abbott's scientific experience with the anti-TNF biologic HUMIRA serves as a strong foundation for our continuing research in immunology. Products in development for the treatment of immune-mediated diseases are designed to selectively inhibit proteins that are responsible for inflammation. In addition to our work with IL-12/23, we are working to advance development of our early discovery programs, including oral therapies, as well as other potential biologic targets.
o Additionally, our proprietary DVD-ig technology represents an innovative approach that can target multiple disease-causing antigens with a single biologic agent.
* Hepatitis C
o Abbott's antiviral program is focused on the treatment of hepatitis C, a disease that affects more than 170 million people worldwide. Abbott has several active hepatitis C programs including our partnership with Enanta Pharmaceuticals to develop protease inhibitors as well as an internal polymerase program.
* Bioabsorbable Drug-Eluting Stent
o Abbott has presented encouraging two-year data from the world's first clinical trial for a fully-bioabsorbable DES to treat coronary artery disease. The bioabsorbable DES is designed to be slowly metabolized by the body and completely absorbed over time.
The company had total sales of $30.7 billion in 2009, a 4.2% increase. International sales were $16.5 billion. Net income for the year was $5.7 billion.
Benefits
Abbott offers employees a pension plan,
matching 401(k), and cash profit sharing.· Comprehensive benefits package includes health,
dental, life and longterm disability insurance.
The company recognizes a total of 11 holidays
each year, including standard holidays and companydesignated
holidays. In addition, Abbott offers paid vacation of three weeks
per year for new employees (prorated in the first year, based
on date of hire).
Abbott opened a $10-million child care
center at its corporate headquarters in 2001. The child care
center is the largest in the state of Illinois. The company also
offers an all-day kindergarten program.
Updated January 27, 2010
|